Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Cancer Research|February 21, 2016
Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 MutationsYuwaraj Kadariya, Mitchell Cheung, Jinfei Xu, et al.
Journal of Cellular Physiology|June 16, 2018
Inactivation of Tp53 and Pten drives rapid development of pleural and peritoneal malignant mesotheliomasEleonora Sementino, Craig W Menges, Yuwaraj Kadariya, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 4, 2016
Inflammation-Related IL1β/IL1R Signaling Promotes the Development of Asbestos-Induced Malignant MesotheliomaYuwaraj Kadariya, Craig W Menges, Jacqueline Talarchek, et al.
Plos One|April 29, 2011
Losses of both products of the Cdkn2a/Arf locus contribute to asbestos-induced mesothelioma development and cooperate to accelerate tumorigenesisDeborah A Altomare, Craig W Menges, Jinfei Xu, et al.
Molecular Cancer Research : MCR|January 27, 2022
Inactivation of p21-Activated Kinase 2 (Pak2) Inhibits the Development of Nf2-Deficient Tumors by Restricting Downstream Hedgehog and Wnt SignalingEleonora Sementino, Yuwaraj Kadariya, Mitchell Cheung, et al.
Cancer Research|June 2, 2019
Inactivation of Bap1 Cooperates with Losses of Nf2 and Cdkn2a to Drive the Development of Pleural Malignant Mesothelioma in Conditional Mouse ModelsAnna-Mariya Kukuyan, Eleonora Sementino, Yuwaraj Kadariya, et al.
Frontiers in Environmental Science|December 3, 2020
Challenging Global Waste Management - Bioremediation to Detoxify AsbestosShannon L Wallis, Edward A Emmett, Robyn Hardy, et al.
Cancer Research|June 15, 2014
Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesotheliomaJinfei Xu, Yuwaraj Kadariya, Mitchell Cheung, et al.
Cancer Research|December 28, 2013
Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axisCraig W Menges, Yuwaraj Kadariya, Deborah Altomare, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2020
Somatic Epigenetic Silencing of RIPK3 Inactivates Necroptosis and Contributes to Chemoresistance in Malignant MesotheliomaYinfei Tan, Eleonora Sementino, Mitchell Cheung, et al.
Pageof 3